Press Releases Keyword Search Year None20192018201720162015 Mar 06, 2019 CRISPR Therapeutics to Participate in Upcoming Investor Conferences Feb 27, 2019 CRISPR Therapeutics Announces Presentations at the American Association for Cancer Research 2019 Annual Meeting Feb 25, 2019 CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2018 Financial Results Feb 25, 2019 CRISPR Therapeutics and Vertex Announce Progress in Clinical Development Programs for the Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001 Feb 21, 2019 CRISPR Therapeutics Proposes New Members to the Board of Directors Feb 19, 2019 CRISPR Therapeutics and StrideBio Expand Exclusive Development and Option Agreement Jan 22, 2019 CRISPR Therapeutics and ProBioGen Sign Collaboration and License Agreement to Develop Novel In Vivo Delivery Technologies Jan 04, 2019 CRISPR Therapeutics and Vertex Announce FDA Fast Track Designation for CTX001 for the Treatment of Sickle Cell Disease
